Pfizer-BioNTech COVID-19 Vaccine (Comirnaty) from Japan
This mRNA-based vaccine is used to immunize against SARS-CoV-2, the virus causing COVID-19. It falls under HTS 3002.41.00.00 as a vaccine for human medicine, specifically designed for prophylactic use against infectious disease.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Ensure compliance with FDA import requirements including prior approval via IND or BLA and cold chain validation for mRNA stability
• Provide certificates of analysis, batch records, and proof of GMP manufacturing to avoid detention at entry